掌跖斑块状银屑病患者的合并症分析
该回顾性匹配研究比较了163例掌跖斑块状银屑病患者与781名对照者的合并症患病率,发现糖尿病、心血管疾病和情绪障碍与掌跖斑块状银屑病显著相关,其中情绪障碍关联最强(OR 6.232)。
要点
- 掌跖斑块状银屑病患者中情绪障碍风险显著升高(OR 6.232)。
- 糖尿病(OR 2.296)和心血管疾病(OR 1.797)亦显著相关。
- 血脂异常、高血压和银屑病关节炎虽更常见但未达统计学显著。
核心结论
- 掌跖斑块状银屑病患者中,糖尿病、心血管疾病和情绪障碍的患病风险显著增加,尤其情绪障碍风险最高。
研究设计与样本
- 回顾性匹配研究,纳入163例2009–2017年接受局部补骨脂素联合UVA治疗的掌跖斑块状银屑病患者和781名对照者,按性别和年龄(±1岁)1:5匹配,采用条件逻辑回归分析。
主要发现
- 糖尿病与掌跖斑块状银屑病显著相关(OR 2.296)。
- 心血管疾病与掌跖斑块状银屑病显著相关(OR 1.797)。
- 情绪障碍与掌跖斑块状银屑病显著相关(OR 6.232)。
- 血脂异常、高血压和银屑病关节炎在患者中更常见,但关联未达统计学显著性。
临床怎么用
- 对掌跖斑块状银屑病患者应关注情绪障碍、糖尿病和心血管疾病的筛查与管理。
局限性
- 研究为回顾性设计,部分数据通过调查问卷收集,样本量相对较小,需前瞻性研究验证。
- 银屑病组在整個随访期间评估合并症,而对照组仅在基线访视时评估,评估时间窗不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Psoriasis has been shown to be associated with several comorbidities. Whether the palmoplantar subtype of plaque psoriasis carries similar risks for comorbidities as generalized plaque psoriasis remains to be defined. OBJECTIVE: To examine the association between palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis. METHODS: We retrospectively compared the prevalence of comorbidities previously found to be associated with generalized plaque psoriasis among 163 patients with palmoplantar plaque psoriasis who had been treated with topical psoralen and ultraviolet A from 2009 to 2017 and a cohort of 781 control individuals. Each patient with psoriasis was matched according to sex and age (±1 year) with up to 5 control individuals. Conditional logistic regression was used to evaluate the associations after matching. RESULTS: Diabetes mellitus (odds ratio [OR], 2.296), cardiovascular disease (OR, 1.797), and most remarkably, mood disorders (OR, 6.232) were significantly associated with palmoplantar plaque psoriasis. Dyslipidemia, hypertension, and psoriatic arthritis were more frequent among patients with palmoplantar plaque psoriasis, but those associations did not reach statistical significance. LIMITATIONS: The retrospective nature of this study, the fact that some data were collected through a survey questionnaire, and the relatively small sample size suggest the need to validate the present data in a prospective manner. Additionally, within the psoriasis group, patients were assessed for the presence of comorbidities during the whole follow-up period, whereas the comorbidities of individuals in the control group were assessed during a baseline visit. CONCLUSIONS: Several comorbidities known to be associated with psoriasis vulgaris were also found to be prevalent in a series of patients with plaque palmoplantar psoriasis. Individuals affected with plaque palmoplantar psoriasis showed a particularly high risk for mood disorders.
引用
- Greenberg R, Goldsmith T, Zeltser D, et al. Comorbidities in patients with palmoplantar plaque psoriasis. J Am Acad Dermatol. 2020. PMID: 32811679. doi:10.1016/j.jaad.2020.03.112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。